Advances in the use of exosomes for the diagnosis and treatment of ovarian cancer [0.03%]
外泌体在卵巢癌诊断和治疗中的应用进展
Jiyu Chen,Qingqing Tan
Jiyu Chen
Ferroptosis-induced remodeling of glycosylation the immune microenvironment and improves survival in pancreatic cancer [0.03%]
铁死亡诱导的糖基化免疫微环境重编程可改善胰腺癌预后
Hao Tan,Haitao Zhang,Jiacheng Gao et al.
Hao Tan et al.
Background: Pancreatic ductal adenocarcinoma (PDAC) is still an aggressive and rapidly progressive malignant tumor of the digestive system. Emerging treatment strategies have yielded limited benefits, primarily due to the...
Prognostic impact of preoperative osteopenia in elderly patients with lung cancer [0.03%]
老年肺癌患者术前骨量减少的预后影响
Shoji Kuriyama,Motoko Konno,Naoko Mori et al.
Shoji Kuriyama et al.
Background: Osteopenia was recently reported to be a factor contributing to a poorer prognosis in various cancers. However, its prognostic impact on non-small cell lung cancer (NSCLC) patients remains unclear. In the pres...
Acute kidney injury predicts mortality, sarcopenia and postoperative morbidity in myxofibrosarcoma patients undergoing surgical resection [0.03%]
急性肾损伤预测黏液纤维肉瘤手术患者死亡率、少肌症和术后并发症发生率
Julian Kylies,Dominik Kylies,Jana K Striefler et al.
Julian Kylies et al.
Background: Myxofibrosarcoma (MFS) is a rare, aggressive soft tissue sarcoma primarily affecting older adults. Despite curative-intent surgery and multimodal therapy, outcomes remain variable. Acute kidney injury (AKI) an...
Predictive value of 18F-FDG-PET/CT for pathologic complete response (pCR) of lesions after neoadjuvant chemotherapy in advanced ovarian cancer [0.03%]
18F-FDG-PET/CT对卵巢癌新辅助化疗后病理完全缓解的预测价值分析
Shiyu Ye,Yun Wang,Runhua Li et al.
Shiyu Ye et al.
Objective: This study aimed to evaluate the ability of 18F-FDG-PET/CT to predict pathological complete response (pCR) in lesions of patients with advanced epithelial ovarian cancer (EOC) following neoadjuvant chemotherapy...
Sarcopenia predicts poor long-term survival but not postoperative complications in gastric cancer surgery: an 18-year retrospective cohort study [0.03%]
sarcopenia预测胃癌手术患者的长期生存而不影响术后并发症：一项18年的回顾性队列研究
Johan Back,Tommi Järvinen,Ville Sallinen et al.
Johan Back et al.
Introduction: Sarcopenia, defined as the loss of skeletal muscle mass and function, is common in gastric cancer (GC) patients and has been associated with adverse outcomes. This study aimed to evaluate the impact of sarco...
Chondroitin sulfate proteoglycan 4 (CSPG4) overexpression as an oncogenic driver and prognostic marker for unfavorable outcomes in hepatocellular carcinoma [0.03%]
软骨素硫酸盐蛋白多糖4(CSPG4)过表达作为肝细胞癌的致癌驱动因子和预后不良标志物
Changjie Ren,Feihu Yan,Hao Xiang et al.
Changjie Ren et al.
Background: A significant challenge in improving outcomes for hepatocellular carcinoma (HCC) patients is the scarcity of reliable prognostic markers and predictive tools. Chondroitin Sulfate Proteoglycan 4 (CSPG4) has sho...
Safety and efficacy of salvage surgery for unresectable hepatocellular carcinoma after conversion with triple therapy: a systematic review and meta-analysis of data from Chinese patients [0.03%]
中国不可切除肝细胞癌经三联疗法转化治疗后的补救性手术安全性和有效性系统评价和 Meta 分析
Qingqing Pang,Xingling Mo,Zhihong Tang et al.
Qingqing Pang et al.
The predictive role of PNI and NRS2002 for postoperative pulmonary complications in ESCC patients undergoing neoadjuvant chemoimmunotherapy followed by McKeown esophagectomy: a retrospective cohort study [0.03%]
术前PNI和NRS2002预测食管癌新辅助化疗免疫治疗后McKeown食管切除术术后肺部并发症的作用：回顾性队列研究
Chunyan Zhang,Xiaojuan Ji,Zhiyun Xu et al.
Chunyan Zhang et al.
Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths, especially in East Asia. McKeown esophagectomy, the standard surgery for advanced ESCC, is often complicated by pulmonary ...
Predictive value of tumor marker index for pathological complete response following neoadjuvant chemoradiotherapy in locally advanced rectal cancer [0.03%]
新辅助放化疗后局部晚期直肠癌病理完全缓解的肿瘤标志物指数预测价值分析
Selami Bayram,Mustafa Serkan Alemdar,Ali Murat Tatli et al.
Selami Bayram et al.
Background: Pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) is associated with favorable outcomes; however, pre-treatment biomarkers that reliably p...